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Abstract:
Background: The thyroid gland and hormonal regulation are among the most important systems to be investigated in pre-term 
infants. This study sought to investigate thyroid hormone levels of  healthy and unhealthy pre-term infants.
Methods: The prospective study included 53 consecutive premature infants admitted to the neonatal intensive care unit within 
a duration of  one year. Of  these preterm babies, 20 were healthy, while 33 had problems such as asphyxia or RDS. Venous 
blood samples were collected at baseline 0-24 hours, 7 and 14 days and FT3, FT4, and TSH levels were determined. Other data 
recorded included demographic characteristics of  the patients and clinical variables.
Results: The most frequent health problems were RDS (87.9%), sepsis (30.3%), and retinopathy of  prematurity (24.2%). The 
mean TSH levels showed a consistent decline at three consequent measurements in both groups, which were always significantly 
lower in unhealthy pre-terms. In both groups, TSH levels showed significant decreases on Day 7 and Day 14 compared to the 
baseline levels (p<005). The levels of  FT3 and FT4 consistently showed significant correlations with gestational week and birth 
weight at each of  the three measurements.
Conclusion: Pre-term infants, especially those having problems, have significant hypothyroxinemia that may require thyroid 
hormone replacement therapy.
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Introduction
Thyroid hormones are the cornerstones of  a complex 
system that plays an important role in the growth and de-
velopment of  children, especially in the development of  
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disruptions of  this system can cause permanent damage. 
Unrecognized early hypothyroidism resulting in mental 
retardation is a striking example of  this condition.1,2
Thanks to the technological improvements in neonatal 
intensive care units, the mortality rate of  premature in-
fants has considerably improved, reducing the limit of  
viability to as early as 24 weeks of  gestational age. This re-
duction in mortality rates of  premature babies has drawn 
attention to increased morbidity issues.3 For those infants 
who have developmental problems in many aspects, im-
proving growth and development to optimum levels is 
among one of  the leading problems to be dealt with.4 
The thyroid gland and hormonal regulation are among 
the most important systems to be studied in pre-term in-
fants.5
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Thyroid dysfunction is a common problem in pre-term 
infants.3,6  Hypothyroxinemia of  prematurity within the 
first month of  life may represent important prognos-
tic information about morbidity and mortality. Thyroid 
hormone synthesis may be disrupted in co-morbid con-
ditions (sepsis, RDS, shock, asphyxia, etc.), worsening 
the metabolism of  premature infants and causing higher 
hormone levels compared to healthy infants.6,7 This study 
aimed to investigate thyroid hormone levels of  healthy 
and unhealthy pre-term infants.
Materials and methods
This prospective study included 53 consecutive prema-
ture infants (26 boys, 27 girls) who were admitted to the 
neonatal intensive care unit of  pediatrics department of  
Okmeydanı Training and Research Hospital, İstanbul, 
Turkey, between August 2009 and August 2010. Of  these 
preterm babies, 20 were healthy (group 1), while 33 had 
problems such as asphyxia, respiratory distress syndrome 
(RDS), or meconium aspiration syndrome (group 2). In-
fants whose mothers had thyroid disease or use of  alco-
hol, cigarettes or drugs during pregnancy and who died 
within the first month of  life were excluded. Approval 
for the study was obtained from the Local Ethics Com-
mittee of  the Okmeydanı Training and Research Hospital 
(No:254/2009). Written informed consent was obtained 
from all the parents.
Data were collected on demographic characteristics of  the 
patients, perinatal risk factors, length of  hospitalization, 
survival, the need for surfactant therapy, antibiotic treat-
ment, and mechanical ventilation, and the development 
of  RDS, necrotizing enterocolitis, sepsis, and retinopathy 
of  prematurity. Gestational age was determined as com-
pleted gestational weeks after the onset of  the last nor-
mal menstrual period by obstetric examination, standard 
obstetric parameters, and the New Ballard Score, which 
was used especially in cases in which data on maternal 
and gestational age were not clearly elicited.8 Growth re-
tardation at birth was assessed by reference to the growth 
curves defined by Lubchenco.9 Small for gestational age 
(SGA) was defined as birth weight below the 10th percen-
tile for the gestational age using the Lubchenco's growth 
curves.9
Venous blood samples (3 ml) were collected from all cas-
es into sterile dry glass tubes at baseline (0-24 hours),7, 
and 14 days and centrifuged within an hour. Blood col-
lection coincided with routine morning blood sampling 
(7 to 9 AM). Levels of  free tri-iodothyronine (FT3), free 
thyroxine (FT4), and thyroid-stimulating hormone (TSH) 
were determined on a Beckman Coulter DXI 800 auto 
analyzer using the immunochemiluminescent method.
Data was analyzed using the NCSS (Number Cruncher 
Statistical System) 2007 and the PASS (Power Analysis 
and Sample Size) 2008 statistical software (Utah, USA). 
Continuous variables were expressed as mean and stan-
dard deviation, and categorical variables as frequencies. 
The Student-t test and Mann-Whitney U-test were used 
to compare the two groups for parameters with and with-
out normal distribution, respectively. For in-group com-
parisons, normally distributed data were compared using 
analysis of  variance for repeated measures, and the Bon-
ferroni test for the assessment of  the day that was associ-
ated with a significant result. The corresponding tests for 
non-normally distributed data were the Friedman test and 
the Wilcoxon signed-rank test. A P value of  less than 0.05 
was considered to be significant.
Results
Data on gender, type of  delivery, gestational week, and 
birth weight of  healthy and unhealthy pre-term babies 
are shown in Table 1. The babies were delivered either 
by caesarean section (92.5%) or vaginal delivery (7.5%) 
at a mean of  32.1±3.2 gestational weeks. The mean 
birth weight of  the babies was 1,740.4±604.9 g (range 
420 to 2,750 g). Group 1 included 7 boys and 13 girls 
with a mean birth weight of  2,085.0±391.3 g. Group 2 
included 19 boys and 14 girls with a mean birth weight 
of  1,531.5±620.1 g. There were no significant differences 
between the two groups with respect to gender, type of  
delivery, gestational week, and birth weight.
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Table 1. Demographic characteristics of the healthy (group 1) 
and unhealthy (group 2) preterm babies 
 






Gender [n (%)] Male 7 (35%) 19 (57.6%) 26 (49.1%) 0.64 Female 13 (65%) 14 (42.4%) 27 (50.9%) 0.83 
Type of 
delivery [n (%)] 
Vaginal delivery 2 (10%) 2 (6.1%) 4 (7.5%) 0.81 
Caesarean section 18 (90%) 31 (93.9%) 49 (92.5%) 0.93 
Gestational weeks 34.2±1.8 30.9±3.3 32.1±3.2 0.16 
Birth weight (g) 2,085.0±391.3 1,531.5±620.1 1,740.4±60.9 0.07 
  
The presenting signs and symptoms in group 2 are shown 
in Table 2, the most frequent problems being RDS 
(87.9%) and sepsis (30.3%).
The mean TSH levels of  the two groups showed a con-
sistent decline at three consequent measurements, which 
were always significantly lower in group 2 than in group 1 
(for Day 1, p=0.004; for Day 7, p=0015; and for Day 14, 
p=0.049). In both groups, TSH levels showed significant 
decreases on Day 7 and Day 14 compared to the baseline 
levels (Table 3).
Table 2. The presenting signs and symptoms in group 2 (n=33) 
 
  n % 
Respiratory distress syndrome 
29 87.9 
Sepsis 10 30.3 
Bronchopulmonary dysplasia 4 12.1 
Meconium aspiration syndrome 3 9.1 
Pneumothorax 2 6.1 
Asphyxia 2 6.1 
Persistent pulmonary hypertension 1 3.0 
Necrotizing enterocolitis 1 3.0 
Surfactant therapy 29 87.9 
  
The mean FT3 levels were significantly higher in group 
1 than in group 2 at baseline and at 7 days, but this dif-
ference was not significant at 14 days (Table 3). Changes 
in FT3 levels in each group at 7 and 14 days showed no 
significant differences from the baseline levels. The mean 
FT4 levels were similar in the two groups at three consec-
utive measurements (Table 3).
The associations of  TSH, FT3 and FT4 levels with ges-
tational week and birth weight were as follows (Table 4): 
TSH showed no correlation with gestational week and 
birth weight at baseline (p>0.05); however, inverse cor-
relations were noted with gestational week and birth 
weight at 7 and 14 days. On the other hand, FT3 and FT4 
levels consistently showed significant correlations with 
gestational week and birth weight at each of  the three 
measurements.
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Table 3. Comparison of the TSH, FT3 and FT4 levels between the two groups 
 
  





+p Group 1 (Mean±SD) 
Group 2 
(Mean±SD) 




Day 1 15.1±13.9 8.0±8.3 0.004 3.1±1.3 2.3±0.6 0.013 1.5±0.4 1.3±0.5 0.118 
Day 7 5.1±3.2 3.8±3.4 0.015 2.8±0.6 2.2±0.5 0.001 1.3±0.4 1.1±0.3 0.055 
Day 
14 3.0±1.5 2.4±1.2 0.049 2.6±0.6 2.2±0.6 0.050 1.3±0.3 1.1±0.3 0.060 
++p 0.001 0.001   0.056 0.823   0.102 0.062   
+ Mann-Whitney U-test; ++ Friedman test. 
Discussion
The most common thyroid function disorder in prema-
ture infants is physiological hypothyroxinemia, followed 
by hypothyroidism of  non-thyroidal causes. In pre-matu-
rity, several factors can inhibit the conversion of  periph-
eral T4 to T3, including hypoxemia, acidosis, infections, 
hypoglycemia, hypocalcemia and malnutrition. Some rare 
conditions include transient secondary/tertiary hypothy-
roidism, transient primary hypothyroidism and perma-
nent primary hypothyroidism.10 Patients with normal free 
T4 levels and transiently high TSH levels are considered 
to have transient elevation of  TSH; low T3 levels in con-
junction with low or normal free T4 and TSH levels are 
linked to non-thyroidal disease (euthyroid sick syndrome); 
a normal TSH level together with a transiently low free 
T4 level is called transient hypothyroxinemia, and a low 
free T4 level accompanied by a high TSH level denotes 
primary hypothyroidism.5,6,10 We found first day TSH lev-
els high and FT4 levels normal in the healthy group and 
we considered this as transient TSH elevation. Except for 
this result, mean FT3 and FT4 levels were found normal 
in both groups.
A low FT4 level and a high TSH level have been reported 
to be risk factors for pre-term delivery, though no asso-
ciation has been shown between FT3 and pre-term de-
livery.11,12 Infants born small for gestational age have also 
been shown to have higher TSH levels than those born 
appropriate for gestational age.13 In our study, while TSH 
showed no correlation with gestational week and birth 
weight at baseline (Day 1), it was inversely correlated with 
gestational week and birth weight at 7 and 14 days. FT3 
and FT4 levels, on the other hand, consistently showed 
significant correlations with gestational week and birth 
weight at each of  the three measurements.
In our study, TSH levels were higher in healthy pre-term 
infants than in unhealthy infants. Normal free T4 and 
transiently high TSH levels were considered transient 
elevation of  TSH. The most frequent factors associated 
with neonatal transient hypothyroidism are maternal an-
ti-thyroid drug use, maternal auto-antibodies, excess io-
dine intake and exposure, or iodine deficiency. Immaturi-
ty of  the hypothalamic-pituitary-thyroid axis may account 
for the higher prevalence of  transient hypothyroidism in 
premature infants than in term infants.14 In our study, 
exclusion criteria included maternal causes of  thyroid 
disease, which are the most frequent causes of  transient 
hypothyroidism, including maternal history of  thyroid 
disease and abnormal thyroid function tests during preg-
nancy. However, this did not ensure elimination of  other 
causes associated with transient hypothyroidism. Empha-
sis was placed rather on the relationship between thyroid 
function tests and complications of  premature newborns.
Thyroid dysfunction is common in infants admitted to in-
tensive care units, most of  which turn out to be euthyroid 
sick syndrome. Abnormal findings are often associated 
with transient increases in TSH during the recovery pe-
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riod of  the condition. Therefore, close monitoring with-
out further treatment usually suffices except in cases in 
which the TSH level is 15-20 mIU / L or remains high 
for longer than a month.15 Larson et al. reported that very 
low-birth-weight babies and infants receiving intensive 
care due to a body weight of  less than 2500 g were at 
an increased risk for transient hypothyroidism and that 
use of  dopamine and iodine resulted in delays in TSH 
elevation.16 In another study, infants with RDS had sig-
nificantly lower levels of  T4, FT4 and T3 on day 5 as 
compared with healthy pre-term infants but had similar 
TSH levels, suggesting that decreased thyroid function 
might be associated with RDS.17 In support of  this find-
ing, FT3 values were significantly lower at 1 and 7 days in 
group 2, of  which 28/33 pre-term babies had RDS. Chen 
et al. found significantly lower levels of  FT3 and FT4 in 
unhealthy pre-term babies as compared with healthy pre-
term babies.18 Chung et al. also found significantly lower 
FT4 levels in babies born before 28 weeks of  gestation.19 
They noted that low FT4 levels sustained during the first 
postnatal week but reached normal levels of  term infants 
within the first two months. In addition, RDS and BPD 
were significantly more common in these infants than in 
the control group. In our study, serum FT4 levels were al-
ways lower in group 2 than in group 1, but the differences 
found at three measurements did not reach significance. 
Overall, in the setting of  prematurity, TSH, FT3 and FT4 
levels were lower in unhealthy infants than in healthy in-
fants.
Thyroid dysfunction has been reported to be more com-
mon in infants with low birth weight due to inadequate 
intrauterine nutrition, hypoxia, and acidosis.20 In addi-
tion, a meta-analysis found that birth weight and gesta-
tion week were closely related to thyroid function tests.21 
We also found significant correlations between thyroid 
function tests and birth weight and gestational age, which 
indicated increased thyroid dysfunction with lower birth 
weight and gestational age.
Our study has a number of  important limitations. Higher 
degrees of  iodine exposure is among the reasons for tran-
sient hypothyroisim in prematüre babies.22 The babies in 
our study were exposed to iodine containing antiseptics 
because of  the procedures such as catheterization, blood 
collection and lumbar puncture in the intensive care unit. 
Pre-term infants in neonatal intensive care units are also 
subject to concomitant drugs, such as dopamine, metoclo-
pramide, aminophylline and steroids to treat their illness, 
which result in transient thyroid dysfunction and affect 
test results.5 TSH and FT4  levels can vary significantly 
over the first 24 h and the first few days of  life. Therefore, 
testing the hormone levels  with routine morning blood 
sampling in the first 24 h of  life is recommened.
Conclusion 
Pre-term infants, especially those having problems, have 
significant hypothyroxinemia during the first weeks of  
life. The majority of  studies on thyroid hormone status 
in pre-term infants have been limited to the first week 
of  life.  We suggest that thyroid function tests should 
be repeated when found normal, especially in unhealthy 
prematures. Hypothyroxinemia represents an important 
risk factor for the development of  pre-term infants, es-
pecially those having problems, and may require thyroid 
hormone replacement therapy for normal development 
and decreased morbidity. However, thyroid hormone 
replacement therapy has been assessed in a small num-
ber of  studies, with varying combinations and doses and 
conflicting results. Even though we have not performed 
hormone replacement in our study, considering the im-
portance of  thyroid hormones in mental and motor de-
velopment, replacement therapy may play an important 
role in reducing mortality and morbidity of  premature 
infants as well as in improving their neuro-developmental 
processes throughout their follow-up. Further studies are 
warranted to substantiate these beneficial effects.
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